NCT00649077View on ClinicalTrials.gov

Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Healthy
Interventions
DRUG

Meloxicam Tablets 15 mg

15mg, single dose fasting

DRUG

Mobic® Tablets 15 mg

15mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00649077 - Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg | Biotech Hunter | Biotech Hunter